PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.52 - 1.58
1.19 - 3.37
354.5K / 984.1K (Avg.)
-1.64 | -0.94
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
8.90%
Positive revenue growth while FSLR is negative. John Neff might see a notable competitive edge here.
9.90%
Positive gross profit growth while FSLR is negative. John Neff would see a clear operational edge over the competitor.
58.94%
Positive EBIT growth while FSLR is negative. John Neff might see a substantial edge in operational management.
-46.05%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
42.34%
Positive net income growth while FSLR is negative. John Neff might see a big relative performance advantage.
42.25%
Positive EPS growth while FSLR is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
42.25%
Positive diluted EPS growth while FSLR is negative. John Neff might view this as a strong relative advantage in controlling dilution.
0.39%
Share count expansion well above FSLR's 0.16%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
0.39%
Diluted share count expanding well above FSLR's 0.13%. Michael Burry would fear significant dilution to existing owners' stakes.
No Data
No Data available this quarter, please select a different quarter.
28.86%
Positive OCF growth while FSLR is negative. John Neff would see this as a clear operational advantage vs. the competitor.
35.38%
Positive FCF growth while FSLR is negative. John Neff would see a strong competitive edge in net cash generation.
No Data
No Data available this quarter, please select a different quarter.
80.88%
5Y revenue/share CAGR under 50% of FSLR's 359.03%. Michael Burry would suspect a significant competitive gap or product weakness.
10.76%
3Y revenue/share CAGR under 50% of FSLR's 68.87%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
-48.95%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
-132.01%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
No Data
No Data available this quarter, please select a different quarter.
-476.02%
Negative 5Y net income/share CAGR while FSLR is 66.12%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-298.04%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
No Data
No Data available this quarter, please select a different quarter.
-13.06%
Negative 5Y equity/share growth while FSLR is at 206.67%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
-34.13%
Negative 3Y equity/share growth while FSLR is at 36.08%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
61.90%
AR growth well above FSLR's 49.45%. Michael Burry fears inflated revenue or higher default risk in the near future.
-9.50%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
0.24%
Asset growth well under 50% of FSLR's 9.01%. Michael Burry sees the competitor as far more aggressive in building resources or capacity.
-3.97%
We have a declining book value while FSLR shows 2.72%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
-0.90%
We’re deleveraging while FSLR stands at 2.09%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
6.04%
R&D growth drastically higher vs. FSLR's 0.02%. Michael Burry fears near-term margin erosion unless breakthroughs are imminent.
11.58%
SG&A declining or stable vs. FSLR's 42.46%. David Dodd sees better overhead efficiency if it doesn't hamper revenue.